I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research, development, and innovation has positioned him as a thought leader in the cell and gene therapy (CGT) industry. With a sharp focus on emerging technologies and strategic growth, Ivan
Imagine a laboratory where complex chemical reactions unfold without constant human oversight, where precision and efficiency are elevated by cutting-edge technology that anticipates and optimizes every step of the process. This vision is becoming a reality with the latest reaction automation
In a quiet suburban home, an elderly man struggles to pour a cup of coffee, his hands trembling uncontrollably as the liquid spills over the counter, a scene repeated daily for millions with Parkinson’s disease (PD). This heartbreaking reality captures the profound impact of a condition that
Imagine a condition so stealthy that it silently weakens bones over decades, only revealing itself through a devastating fracture that could rob a person of independence or even life—yet it’s rarely discussed in relation to half the population. Osteoporosis, long branded as a women’s health
What if a single misplaced molecule could halt the progress of a life-saving drug? In the fast-evolving world of biopharmaceuticals, oligonucleotide therapeutics stand at the forefront, offering hope for untreatable genetic disorders and rare diseases with their ability to target conditions at the
In the rapidly evolving landscape of cancer treatment, few innovations have captured as much attention as chimeric antigen receptor T cell (CAR-T) therapy, a groundbreaking method that reprograms a patient’s immune cells to attack cancer with remarkable precision. Originally developed as a niche
What happens when the tools used to fight one of the deadliest cancers fail to tell the full story, and how can a new approach change the game? Glioblastoma, an aggressive brain cancer with a survival rate of less than 15 months for most patients, has long evaded effective treatment, but a
Introduction Imagine a world where life-saving cancer treatments, once out of reach due to exorbitant costs and lengthy production times, become accessible to patients in desperate need through groundbreaking innovations. CAR-T therapy, a revolutionary immunotherapy that modifies a patient's T
Imagine a world where the intricate labyrinth of the human brain is no longer a mystery, but a detailed map accessible to scientists and doctors alike, thanks to the seamless integration of artificial intelligence with neuroscience, revolutionizing how brain function, behavior, and disease are
Imagine a world where detecting cancer is as simple as breathing into a device or collecting a urine sample at home, with results available almost instantly through a smartphone app, transforming the way we approach early diagnosis. This vision, once confined to science fiction, is rapidly becoming
